Sen. Christopher Murphy

Maddy summaryThis resolution supports the New Heights Bid Committee's effort to secure the 2027 FIFA Women's World Cup for a U.S.-Mexico joint bid. It asks Congress to recognize the committee's work and encourages federal agencies to help meet hosting requirements. If selected, the resolution states Congress would consider future legislation to support the event's infrastructure and economic goals. The resolution does not create new laws or directly affect specific groups, as it is a formal expression of support for the bid process.

Maddy summaryThis resolution (SRES 534) designates January as "Muslim-American Heritage Month" to officially recognize and celebrate the contributions of Muslim Americans to U.S. society. It directly affects Muslim Americans by formally acknowledging their cultural, historical, and economic impacts, including their roles in fields like architecture, business, military service, and the arts. The resolution supports the designation, honors Muslim Americans' integral role in the nation's economy and identity, and urges public observance through ceremonies and activities. As a non-binding Senate resolution, it does not create new laws but serves as a symbolic gesture of recognition.

Maddy summaryThe SHIFT Act requires federal fishery managers to account for climate change impacts, such as shifting fish populations and habitat changes, when setting fishing quotas and managing coastal fisheries. It establishes a process for regional fishery councils to coordinate management when fish stocks move across state lines, including deadlines for councils to agree on a lead council or joint planning, with the Secretary stepping in if they fail to reach consensus. The bill also mandates that new fisheries or fishing gear can only be added to official management lists after councils analyze potential environmental and community impacts, and requires councils to review these lists every five years. These changes aim to improve adaptive management of fisheries in response to climate shifts while ensuring consistent oversight across state boundaries.

Maddy summaryThis bill increases the Child and Dependent Care Tax Credit for eligible taxpayers. It raises the maximum credit rate from 35% to 50% (with income phaseouts), doubles the annual dollar limits from $3,000/$6,000 to $8,000/$16,000 for one/two or more dependents, and makes the credit refundable for qualifying taxpayers. The credit becomes refundable, meaning families can receive payments even if they owe no income tax. The bill also includes automatic annual inflation adjustments starting in 2025 to maintain the credit's value. It directly benefits working families with childcare costs, particularly those earning between $125,000 and $400,000 in adjusted gross income.

Maddy summarySRES 530 is a Senate resolution designating January 23, 2024, as "Maternal Health Awareness Day" to highlight maternal health challenges in the U.S., including high mortality rates and racial disparities. It encourages federal, state, tribal, and local governments, as well as healthcare providers, to take action on improving maternal health outcomes and reducing inequities. The resolution references statistics showing Black, American Indian, and Alaska Native individuals face significantly higher risks of maternal death and that rural communities often lack access to obstetric care, but it does not create new laws or funding.

Maddy summarySRES 523 is a Senate resolution honoring the late Senator Herb Kohl of Wisconsin. The resolution expresses the Senate's sorrow at his death, directs the Secretary of the Senate to communicate it to the House of Representatives and send a copy to his family, and instructs the Senate to adjourn as a mark of respect. This procedural resolution does not create new laws or affect policy, but formally commemorates Kohl's service and legacy. It was introduced by a bipartisan group of Senators and passed unanimously on January 11, 2024.

Maddy summaryThis bill establishes a federal right for patients to access fertility treatments without unreasonable restrictions, protects health care providers who offer these services, and requires insurance coverage for such treatments. It guarantees patients the right to continue ongoing treatments under written agreements and retain control over reproductive materials. States cannot impose requirements that are more burdensome than those for comparable medical procedures or that don’t significantly advance safety. Violations can be challenged in federal court by the government, patients, or providers, while states may still enforce health/safety regulations that are necessary and least restrictive.

Maddy summaryS 3557 requires the Secretary of Health and Human Services (through the FDA) to create a report within one year of enactment. The report must outline a plan for reviewing approved opioid pain medicines, specifically considering their public health impact in safety and effectiveness assessments. It also mandates including public input, FDA actions on opioid safety, a timeline for potential label changes or enforcement, and steps to support non-addictive pain treatment development. This bill directly affects the FDA's regulatory process for opioid drugs and its approach to pain medicine innovation. The focus is on structuring a transparent review process, not on mandating specific outcomes for opioids.

Maddy summarySRES 507 is a symbolic Senate resolution designating September 25, 2023, as "National Ataxia Awareness Day." It aims to increase public and medical awareness of ataxia - a rare neurological condition affecting movement coordination, with symptoms including balance issues, speech difficulties, and swallowing problems. The resolution highlights the need for better diagnosis, access to care, and accelerated research toward treatments for the estimated 200,000 Americans affected by ataxia. As a non-binding resolution, it does not create new laws or funding but encourages nationwide awareness efforts.

Maddy summaryThis Senate resolution (SRES 510) expresses the Senate's support for respecting the FDA's scientific determination that mifepristone - a medication used for early pregnancy termination - is safe and effective. It calls for abortion care policies to be "equitable and based on science," emphasizing the FDA's authority to regulate the drug without interference, including its 2023 update allowing mail-order access. The resolution directly addresses the impact of state restrictions on medication abortion, noting that such policies disproportionately affect Black and Indigenous people, people of color, low-income individuals, rural communities, and other marginalized groups. As a non-binding resolution, it does not change laws but urges alignment with FDA science to protect access to this time-sensitive care.